Factors associated with preference for sildenafil citrate and tadalafil for treating erectile dysfunction in men naïve to phosphodiesterase 5 inhibitor therapy:post hocanalysis of data from a multicentre, randomized, open-label, crossover study-Reference-Cited by-同舟云学术

Factors associated with preference for sildenafil citrate and tadalafil for treating erectile dysfunction in men naïve to phosphodiesterase 5 inhibitor therapy:post hocanalysis of data from a multicentre, randomized, open-label, crossover study

Published:2007-06-05 Issue:1 Volume:100 Page:122-129
ISSN:1464-4096
Container-title:BJU International
language:en
Short-container-title:

Author:

Eardley Ian,Montorsi Francesco,Jackson Graham,Mirone Vincenzo,Chan Melanie L-S.,Loughney Kate,Vail G. Matthew,Beardsworth Anthony

Publisher

Wiley

Subject

Urology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/j.1464-410X.2007.06916.x/fullpdf

Reference13 articles.

1. NIH Consensus Conference. Impotence. NIH Consensus Development Panel on Impotence;Anonymous.;JAMA,1993

2. Oral sildenafil in the treatment of erectile dysfunction. Sildenafil Study Group;Goldstein;N Engl J Med,1998

3. The efficacy and tolerability of vardenafil, a new, oral, selective phosphodiesterase type 5 inhibitor, in patients with erectile dysfunction: the first at-home clinical trial;Porst;Int J Impot Res,2001

4. On-demand IC351 (Cialis) enhances erectile function in patients with erectile dysfunction;Padma-Nathan;Int J Impot Res,2001

5. An open-label, multicentre, randomized, crossover study comparing sildenafil citrate and tadalafil for treating erectile dysfunction in men naive to phosphodiesterase 5 inhibitor therapy;Eardley;BJU Int,2005

Cited by 37 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Treatment preferences of patients with erectile dysfunction: a systematic review of randomized controlled trials;Minerva Urology and Nephrology;2024-03

2. Re: Moritz von Büren, Severin Rodler, Isabell Wiesenhütter, et al. Digital Real-world Data Suggest Patient Preference for Tadalafil over Sildenafil in Patients with Erectile Dysfunction. Eur Urol Focus 2022;8:794–802;European Urology Focus;2023-09

3. A review on pharmacological options for the treatment of erectile dysfunction: state of the art and new strategies;Expert Opinion on Pharmacotherapy;2023-06-10

4. Immediate post-operative PDE5i therapy improves early erectile function outcomes after robot assisted radical prostatectomy (RARP);Journal of Robotic Surgery;2021-02-08

5. Immediate post-operative PDE5i Therapy improves early Erectile Function Outcomes after Robot Assisted Radical Prostatectomy (RARP);2020-09-28